Dysregulation of RasGRP1 in rheumatoid arthritis and modulation of RasGRP3 as a biomarker of TNFα inhibitors

Marie-Laure Golinski(Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers), Thierry Lequerré(Normandie Université)
Arthritis Research & Therapy
December 1, 2015
Cited by 24


Related Papers